TMCnet News

Global High-density Multiplexed Diagnostic Assays Market to Grow at a CAGR of 15% During 2017-2021 - Driven by Introduction of Automated Multiplexed PCR Assays - Research and Markets

[June 27, 2017]

Global High-density Multiplexed Diagnostic Assays Market to Grow at a CAGR of 15% During 2017-2021 - Driven by Introduction of Automated Multiplexed PCR Assays - Research and Markets

Research and Markets has announced the addition of the "Global High-density Multiplexed Diagnostic Assays Market 2017-2021" report to their offering.

The global high density multiplexed diagnostic assays market to grow at a CAGR of 15.01% during the period 2017-2021.

The report, Global High density multiplexed diagnostic assays Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend in the market is introduction of automated multiplexed PCR (News - Alert) assays. There are automated multiplex systems for simultaneously screening hepatitis B virus, hepatitis C virus, and HIV-1 in blood donations. This helps in reduced hands-on time and elimination of errors with high sensitivity and specificity.

According to the report, one driver in the market is increasing equipment rental agreements. Most of the instruments such as clinical chemistry analyzers, immunochemistry analyzers, and multiplexed diagnostic equipment used in the IVD market are provided for rental or lease to the end-users. They need to pay for the initial installations and consumables. Leasing the high-cost instruments is an effective and convenient purchasing alternative for the end-users with limited budgets.

Key vendors